Skip to main content
Veterinary Medicines

Linco-Spectin Sterile Solution for injection for pigs, non-ruminating calves, dogs and cats

Authorised
  • Lincomycin hydrochloride
  • Spectinomycin sulfate

Product identification

Medicine name:
Linco-Spectin Sterile Solution for injection for pigs, non-ruminating calves, dogs and cats
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin sulfate
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    54.49
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin sulfate
    129.51
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 100ml multi-dose colourless Type 1 (Ph.Eur) glass vial with butyl rubber stopper and aluminium overseal.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/041/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."